Modulation of vascular tone and glycerol levels measured by in situ microdialysis in rat adipose tissue

被引:10
作者
Darimont, C [1 ]
SaintMarc, P [1 ]
Ailhaud, G [1 ]
Negrel, R [1 ]
机构
[1] UNIV NICE, FAC SCI, CTR BIOCHIM, UMR 134 CNRS, F-06108 NICE 2, FRANCE
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 1996年 / 271卷 / 04期
关键词
blood flow; prostacyclin; isoproterenol; vasodilatation; lipolysis; CELL-DIFFERENTIATION; ANGIOTENSIN-II; BLOOD-FLOW; PROSTACYCLIN; GLUCOSE; PROSTAGLANDINS; STIMULATION; EFFECTOR; MUSCLE;
D O I
10.1152/ajpendo.1996.271.4.E631
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Changes in blood flow induced by the beta-adrenoceptor agonist isoproterenol(Iso) and a stable analogue of the major metabolite of arachidonic acid in adipose tissue, carbaprostacyclin (cPGI(2)), have been studied in rat periepididymal fat pad with in situ microdialysis by measuring the distribution ratio of 0.2% ethanol in the dialysate (outflow) to that in the perfusate (inflow) (O/I ratio). Local perfusions of 1 mu M cPGI(2) or 1 mu M Iso led to reversible decreases of the O/I ratio that were similar to the decrease induced by the vasodilating reference drug hydralazine (Hydra, 630 mu M) Interestingly, a continuous perfusion of Hydra at a submaximal vasodilating concentration (63 mu M) was sufficient to prevent further vasodilatation induced by Iso or cPGI(2). To take advantage of this observation, experiments were designed to evaluate the influence of the vasodilating effect of Iso or cPGI(2) on the ability of either to induce lipolysis in vivo. The results showed that the vasodilating effect of Iso could contribute to glycerol removal from the extracellular fluid and demonstrated that cPGI(2) was devoid of lipolytic activity.
引用
收藏
页码:E631 / E635
页数:5
相关论文
共 21 条
  • [1] COMPARISON IN ANESTHETIZED DOGS OF THE ANTI-AGGREGATORY AND HEMODYNAMIC-EFFECTS OF PROSTACYCLIN AND A CHEMICALLY STABLE PROSTACYCLIN ANALOG, 6A-CARBA-PGI2 (CARBACYCLIN)
    AIKEN, JW
    SHEBUSKI, RJ
    [J]. PROSTAGLANDINS, 1980, 19 (04): : 629 - 643
  • [2] MICRODIALYSIS OF ADIPOSE-TISSUE AND BLOOD FOR INVIVO LIPOLYSIS STUDIES
    ARNER, P
    BOLINDER, J
    ELIASSON, A
    LUNDIN, A
    UNGERSTEDT, U
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (05): : E737 - E742
  • [3] ARNER P, 1990, J PHARMACOL EXP THER, V254, P284
  • [4] In situ assessment of the role of the beta(1)-, beta(2)- and beta(3)-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue
    Barbe, P
    Millet, L
    Galitzky, J
    Lafontan, M
    Berlan, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (05) : 907 - 913
  • [5] Bernt E.G., 1974, Methods of enzymatic analysis, P1499
  • [6] RADIOMETRIC ASSAYS FOR GLYCEROL, GLUCOSE, AND GLYCOGEN
    BRADLEY, DC
    KASLOW, HR
    [J]. ANALYTICAL BIOCHEMISTRY, 1989, 180 (01) : 11 - 16
  • [7] AUTOCRINE CONTROL OF ADIPOSE CELL-DIFFERENTIATION BY PROSTACYCLIN AND PGF2-ALPHA
    CATALIOTO, RM
    GAILLARD, D
    MACLOUF, J
    AILHAUD, G
    NEGREL, R
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1091 (03) : 364 - 369
  • [8] DARIMONT C, 1994, INT J OBESITY, V18, P783
  • [9] DIFFERENTIATION OF PREADIPOSE CELLS - PARACRINE ROLE OF PROSTACYCLIN UPON STIMULATION OF ADIPOSE-CELLS BY ANGIOTENSIN-II
    DARIMONT, C
    VASSAUX, G
    AILHAUD, G
    NEGREL, R
    [J]. ENDOCRINOLOGY, 1994, 135 (05) : 2030 - 2036
  • [10] DEMONSTRATION OF AN IN-VIVO FUNCTIONAL BETA(3)-ADRENOCEPTOR IN MAN
    ENOCKSSON, S
    SHIMIZU, M
    LONNQVIST, F
    NORDENSTROM, J
    ARNER, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) : 2239 - 2245